# PERJETA

NDC: 50242-145
Generic name: Pertuzumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20120608

FDA application: BLA125409

## Active ingredients

- PERTUZUMAB: 30 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff